Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial is evaluating Azetukalner versus placebo for depressive episodes in bipolar disorder (bipolar I or II); the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azetukalner

Snippet

Sponsor: Xenon Pharmaceuticals Inc. | Conditions: Bipolar Disorder, Bipolar Depression | Phase 3 | Status: RECRUITING